BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30693819)

  • 1. Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes.
    Elzoghby AO
    Nanomedicine (Lond); 2019 Mar; 14(6):649-653. PubMed ID: 30693819
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.
    Dhadde SB; Patil JS; Chandakavathe BN; Thippeswamy BS; Kavatekar MG
    Crit Rev Ther Drug Carrier Syst; 2020; 37(5):407-434. PubMed ID: 33389846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 5. Impacts of nanotechnology on medicinal chemistry and drug discovery.
    Yan B
    Curr Med Chem; 2011; 18(14):2044. PubMed ID: 21517771
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent review of novel nanostructrued devices, nanofabrication methods and applications in nanofluidics and nanomedicine.
    Michael Chen CY
    Recent Pat Nanotechnol; 2012 Jun; 6(2):114-23. PubMed ID: 22181669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications".
    Shah S; Rangaraj N; Laxmikeshav K; Sampathi S
    Int J Pharm; 2020 May; 581():119268. PubMed ID: 32240803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the salting-out technique on the preparation of colloidal particulate systems for pharmaceutical applications.
    Mendoza-Muñoz N; Quintanar-Guerrero D; Allémann E
    Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):236-49. PubMed ID: 22734871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine-Based Approaches for mRNA Delivery.
    Uchida S; Perche F; Pichon C; Cabral H
    Mol Pharm; 2020 Oct; 17(10):3654-3684. PubMed ID: 32845639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conference Scene: nanomedicine kindles the development of the 'elixir of life'.
    Jain S; Das M
    Nanomedicine (Lond); 2011 Jun; 6(4):599-603. PubMed ID: 21718173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of synthetic and natural polymers: next generation nanomedicines?
    Alexander C
    Nanomedicine (Lond); 2008 Dec; 3(6):749-51. PubMed ID: 19025448
    [No Abstract]   [Full Text] [Related]  

  • 17. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
    Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
    Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles and their Application in Nanomedicine.
    Rajabi M; Mousa SA
    Curr Pharm Biotechnol; 2016; 17(8):662-72. PubMed ID: 27087491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnological applications in medicine.
    Caruthers SD; Wickline SA; Lanza GM
    Curr Opin Biotechnol; 2007 Feb; 18(1):26-30. PubMed ID: 17254762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Nanotechnology for Cancer Therapy.
    Kumar V; Palazzolo S; Bayda S; Corona G; Toffoli G; Rizzolio F
    Theranostics; 2016; 6(5):710-25. PubMed ID: 27022418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.